Drug
Etripamil clinical trials
Also written MSP-2017.
Keep track of what changes. Save the etripamil studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2018 (2)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 6
Milestone Pharmaceuticals Inc. (6) · Corxel Pharmaceuticals (1)
Related medicines
As reviewed, each with the page that says it.
- One of Calcium Channel Blockers source
Studies
Open first, then newest update. How each study uses etripamil is read from its arms, and is right about nine times in ten.
Testing it · 7
- ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3RecruitingPhase 3Milestone Pharmaceuticals Inc.NCT06716021Written as Etripamil
- Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302TerminatedPhase 3Milestone Pharmaceuticals Inc.NCT03635996Written as Etripamil NS 70 mg
- ReVeRA-201: Etripamil in Atrial Fibrillation, Phase 2CompletedPhase 2Milestone Pharmaceuticals Inc.NCT04467905Written as Etripamil
- Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT).TerminatedPhase 3Milestone Pharmaceuticals Inc.NCT03464019Written as Etripamil
- Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303CompletedPhase 3Milestone Pharmaceuticals Inc.NCT04072835Written as Etripamil NS
- A Study of Etripamil in Healthy SubjectsCompletedPhase 1Corxel PharmaceuticalsNCT05511870Written as Etripamil Nasal Spray 70mg
- Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus RhythmCompletedPhase 2Milestone Pharmaceuticals Inc.NCT02296190Written as Etripamil
Codes
What other systems call etripamil · ClinicalTrials.gg INT001253
- MeSH (NLM) C000656646etripamilConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) S82A18Y42PETRIPAMILConfirmed FDA, NLM, Wikidata
- Wikidata Q27289030etripamilConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C169972EtripamilOne source FDA
- DrugBank DB12605One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000656646 | etripamil | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | S82A18Y42P | ETRIPAMIL | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27289030 | etripamil | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C169972 | Etripamil | One source FDA |
| DrugBank | DB12605 | — | One source Wikidata |
Also registered as etripamil hydrochloride (UNII 9TA9AC3H8Z).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.